59,690 Shares in Sabra Healthcare REIT, Inc. $SBRA Acquired by Fox Run Management L.L.C.

Key Points

• Fox Run Management L.L.C. acquired 59,690 shares of Sabra Healthcare REIT, valued at approximately $1,043,000, marking a new position for the institutional investor in the first quarter.
• Analysts upgraded Sabra Healthcare REIT’s target price, with JMP Securities raising it from $20.00 to $22.00, and a consensus rating of “Moderate Buy” is currently held by investment analysts.
• The company announced a $0.30 quarterly dividend to be paid on August 29th, representing a 6.5% yield, despite a high dividend payout ratio of 157.89%.

Fox Run Management L.L.C. purchased a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 59,690 shares of the real estate investment trust's stock, valued at approximately $1,043,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Northern Trust Corp increased its position in shares of Sabra Healthcare REIT by 27.7% during the fourth quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock valued at $72,214,000 after buying an additional 905,466 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of Sabra Healthcare REIT by 1.8% during the first quarter. Bank of New York Mellon Corp now owns 4,114,215 shares of the real estate investment trust's stock valued at $71,875,000 after purchasing an additional 74,564 shares during the period. Nuveen LLC bought a new position in shares of Sabra Healthcare REIT during the first quarter valued at approximately $61,791,000. Janus Henderson Group PLC raised its holdings in shares of Sabra Healthcare REIT by 23.1% during the fourth quarter. Janus Henderson Group PLC now owns 3,504,809 shares of the real estate investment trust's stock valued at $60,720,000 after acquiring an additional 657,950 shares in the last quarter. Finally, Nuveen Asset Management LLC raised its holdings in Sabra Healthcare REIT by 30.8% in the fourth quarter. Nuveen Asset Management LLC now owns 3,378,733 shares of the real estate investment trust's stock worth $58,520,000 after purchasing an additional 795,902 shares in the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Trading Up 0.1%

Shares of Sabra Healthcare REIT stock traded up $0.01 on Friday, reaching $18.46. The company had a trading volume of 2,862,912 shares, compared to its average volume of 2,636,462. The firm has a market cap of $4.43 billion, a price-to-earnings ratio of 24.29, a P/E/G ratio of 1.53 and a beta of 0.86. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. The firm's 50-day moving average price is $18.33 and its two-hundred day moving average price is $17.62. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%. The company had revenue of $189.15 million during the quarter, compared to analysts' expectations of $185.64 million. During the same quarter in the previous year, the business earned $0.36 EPS. Sabra Healthcare REIT's revenue was up 7.4% compared to the same quarter last year. As a group, research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Friday, August 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.5%. The ex-dividend date of this dividend is Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is currently 157.89%.

Analyst Ratings Changes

Several brokerages have recently weighed in on SBRA. Scotiabank raised their price target on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a report on Monday, June 23rd. JMP Securities raised their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research note on Wednesday, August 6th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $20.00.

Insider Transactions at Sabra Healthcare REIT

In other news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total value of $200,420.00. Following the transaction, the director directly owned 64,725 shares of the company's stock, valued at approximately $1,179,289.50. This represents a 14.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.10% of the stock is owned by corporate insiders.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.